Esther W. Barrow

Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis

Ze‐Qi Xu, William W. Barrow, William J. Suling et al. · Bioorganic & Medicinal Chemistry · 2004 · 103 citations

Pulmonary Tuberculosis, Antiviral Compound, Health Sciences +13

Antimycobacterial Activities of 2,4-Diamino-5-Deazapteridine Derivatives and Effects on Mycobacterial Dihydrofolate Reductase

William J. Suling, Lainne E. Seitz, Vibha Pathak et al. · Antimicrobial Agents and Chemotherapy · 2000 · 73 citations · Full text

Susceptibilities of Mycobacterium tuberculosis and Mycobacterium avium complex to lipophilic deazapteridine derivatives, inhibitors of dihydrofolate reductase

William J. Suling, Robert C. Reynolds, Esther W. Barrow et al. · Journal of Antimicrobial Chemotherapy · 1998 · 57 citations · Full text

Antimicrobial Chemotherapy, Pharmaceutical Chemistry, Mycobacterium Avium Complex +19

Inhibition of Antibiotic-Resistant <i>Staphylococcus aureus</i> by the Broad-Spectrum Dihydrofolate Reductase Inhibitor RAB1

Christina R. Bourne, Esther W. Barrow, Richard A. Bunce et al. · Antimicrobial Agents and Chemotherapy · 2010 · 44 citations · Full text

Bioorganic Chemistry, Antibiotic Adjuvant, Molecular Biology +23

Crystal Structure of <i>Bacillus anthracis</i> Dihydrofolate Reductase with the Dihydrophthalazine-Based Trimethoprim Derivative RAB1 Provides a Structural Explanation of Potency and Selectivity

Christina R. Bourne, Richard A. Bunce, Philip C. Bourne et al. · Antimicrobial Agents and Chemotherapy · 2009 · 43 citations · Full text